(Q35624610)

9 August 2017

title

The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective (English)

1 reference

9 August 2017

1 reference

1

1 reference

9 August 2017

Anthony Avery

4

0 references

author name string

Janet Krska

series ordinal

2

1 reference

9 August 2017

Elizabeth Murphy

series ordinal

3

1 reference

9 August 2017

Yellow Card Study Collaboration

series ordinal

5

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

British Journal of Clinical Pharmacology

9 August 2017

published in

1 reference

9 August 2017

volume

72

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

806-822

1 reference

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243015

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243015

The missing voice of patients in drug-safety reporting

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243015

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243015

Patients' role in reporting adverse drug reactions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243015

Reasons for reporting adverse drug reactions--some thoughts based on an international review

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243015

Consumer adverse drug reaction reporting: a new step in pharmacovigilance?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243015

Patient reporting of potential adverse drug reactions: a methodological study

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3243015

What motivates patients to report an adverse drug reaction?

12 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03990.X

Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03990.X

Attitudes among hospital physicians to the reporting of adverse drug reactions in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03990.X

Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03990.X

Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21496066

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Attitudes to reporting adverse drug reactions in northern Sweden

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21496066

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2011.03990.X

1 reference

9 August 2017

1 reference

9 August 2017

1 reference